This study tested an experimental drug called CVN424 in 64 people with early Parkinson's disease who were not yet taking other Parkinson's medications. For 12 weeks, half received CVN424 and half received a placebo. The goal was to see if the drug could improve movement and daily…
Phase: PHASE2 • Sponsor: Cerevance Beta, Inc. • Aim: Symptom relief
Last updated May 26, 2026 09:52 UTC